Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-01-29, Stock:ABT, The news for the past five days is as follows:
2020-01-22: NEWS1: ABT Options Traders Pour In as Stock Hits New High.NEWS2: This local regenerative medicine company is plotting its IPO.NEWS3: Health stocks reverse coronavirus gains as one analyst says the market is overreacting.NEWS4: Abbott beats revenue projections as sales outperform previous year.NEWS5: Abbott hits all-time high on quarterly revenue beat.NEWS6: Breaking Q4 Earnings News.NEWS7: Incoming Abbott CEO says not looking to do any deals.NEWS8: Chicago Econ Numbers & More Q4 Earnings: JNJ, ABT, FITB.NEWS9: Abbott (ABT) Q4 Earnings Match Estimates, Revenues Beat Mark.NEWS10: Health Giant Abbott Labs Beats Fourth-Quarter Sales Views And Rises In Buy Zone.NEWS11: Dow Trades Higher as IBM Jumps, S&P 500 and Nasdaq&nbsp;Set Record Highs.NEWS12: Abbott (ABT) Meets Q4 Earnings Estimates.NEWS13: Shares of Abbott Labs are up 1%; sales are up 7%.NEWS14: Drug, nutrition product sales power Abbott's revenue beat.NEWS15: Abbott Laboratories Earnings Meet, Sales Top; ABT Stock Rises In Buy Zone.NEWS16: Dow Holds Higher but Loses Momentum as Boeing Falters.NEWS17: Dow Gets Lift From IBM, S&P 500 and Nasdaq Hit Records.NEWS18: Abbott Labs Hits Mark on Fourth-Quarter Earnings, Boosts Guidance.NEWS19: Abbott Labs Earnings inline, Revenue Beats In Q4.
2020-01-23: NEWS1: The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment.NEWS2: This Medical Giant Just Topped An Entry — Should You Buy ABT Stock Now?.
2020-01-24: NEWS1: Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease.
2020-01-27: nan
2020-01-28: NEWS1: How Alameda — again — became a biotech hotspot.NEWS2: Should You Care About Abbott Laboratories’s (NYSE:ABT) Investment Potential?.

Answer: Decrease